The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
Open accessAbstract
Over the past decades, a large number of drugs as well as drug candidates with poor dissolution characteristics have been witnessed, which invokes great interest in enabling formulation of these active ingredients. Poorly water-soluble drugs, especially biopharmaceutical classification system (BCS) II ones, are preferably designed as oral dosage forms if the dissolution limit can be broken through. Minimizing a drug’s size is an effective means to increase its dissolution and hence the bioavailability, which can be achieved by specialized dispersion techniques. This article reviews the most commonly used dispersion techniques for pharmaceutical processing that can practically enhance the dissolution and bioavailability of poorly water-soluble drugs. Major interests focus on solid dispersion, lipid-based dispersion (nanoencapsulation), and liquisolid dispersion (drug solubilized in a non-volatile solvent and dispersed in suitable solid excipients for tableting or capsulizing), covering the formulation development, preparative technique and potential applications for oral drug delivery. Otherwise, some other techniques that can increase the dispersibility of a drug such as co-precipitation, concomitant crystallization and inclusion complexation are also discussed. Various dispersion techniques provide a productive platform for addressing the formulation challenge of poorly water-soluble drugs. Solid dispersion and liquisolid dispersion are most likely to be successful in developing oral dosage forms. Lipid-based dispersion represents a promising approach to surmounting the bioavailability of low-permeable drugs, though the technique needs to traverse the obstacle from liquid to solid transformation. Novel dispersion techniques are highly encouraged to develop for formulation of poorly water-soluble drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
Vasconcelos, T., Sarmento, B., & Costa, P. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.09.005 · Cited by 1,566
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Physico-chemical stability of colloidal lipid particles
Heurtault, B. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00331-4 · Cited by 837
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs
Vo, C. L.-N., Park, C., & Lee, B.-J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.007 · Cited by 651
Pharmaceutical cocrystals and poorly soluble drugs
Thakuria, R., Delori, A., Jones, W., Lipert, M. P., Roy, L., & Rodríguez-Hornedo, N. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.043 · Cited by 614
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Mirzaei, H., Shakeri, A., Rashidi, B., Jalili, A., Banikazemi, Z., & Sahebkar, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.098 · Cited by 517
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Polymeric mixed micelles as nanomedicines: Achievements and perspectives
Cagel, M., Tesan, F. C., Bernabeu, E., Salgueiro, M. J., Zubillaga, M. B., Moretton, M. A., & Chiappetta, D. A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.12.019 · Cited by 417
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Physical chemistry of supersaturated solutions and implications for oral absorption
Taylor, L. S., & Zhang, G. G. Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.006 · Cited by 392
Amorphous solid dispersions: Rational selection of a manufacturing process
Vasconcelos, T., Marques, S., das Neves, J., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.012 · Cited by 380
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
Lipid-based formulations for oral administration of poorly water-soluble drugs
Mu, H., Holm, R., & Müllertz, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.054 · Cited by 328
Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization
Elnaggar, Y. S. R., El-Massik, M. A., & Abdallah, O. Y. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.015 · Cited by 316
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Telange, D. R., Patil, A. T., Pethe, A. M., et al. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.12.009 · Cited by 278
Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
Karagianni, A., Malamatari, M., & Kachrimanis, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010018 · Cited by 250
Teixeira, M. C., Carbone, C., & Souto, E. B. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.07.001 · Cited by 228
Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parmar, G. R. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.03.002 · Cited by 223
Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice
Ragelle, H., Crauste-Manciet, S., Seguin, J., Brossard, D., Scherman, D., Arnaud, P., & Chabot, G. G. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.025 · Cited by 213
Biotinylated liposomes as potential carriers for the oral delivery of insulin
Zhang, X., Qi, J., Lu, Y., He, W., Li, X., & Wu, W. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.07.011 · Cited by 194
Self-citationNanostructured Lipid Carriers: Versatile Oral Delivery Vehicle
Poonia, N., Kharb, R., Lather, V., & Pandita, D. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0030 · Cited by 194
Makwana, V., Jain, R., Patel, K., Nivsarkar, M., & Joshi, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.014 · Cited by 189
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
Chen, M.-L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.010 · Cited by 182
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 177
B. Shekhawat, P., & B. Pokharkar, V. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.005 · Cited by 176
Bandyopadhyay, S., Katare, O. P., & Singh, B. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2012.05.019 · Cited by 174
Improving oral bioavailability of nutraceuticals by engineered nanoparticle-based delivery systems
Yao, M., McClements, D. J., & Xiao, H. (2015) · Current Opinion in Food Science · doi:10.1016/j.cofs.2014.12.005 · Cited by 171
Tan, A., Rao, S., & Prestidge, C. A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1107-3 · Cited by 167
Elnaggar, Y., Freag, & Abdallah (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s45231 · Cited by 165
Carvedilol dissolution improvement by preparation of solid dispersions with porous silica
Planinšek, O., Kovačič, B., & Vrečer, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.035 · Cited by 164
Novel strategies for the formulation and processing of poorly water-soluble drugs
Göke, K., Lorenz, T., Repanas, A., Schneider, F., Steiner, D., Baumann, K., Bunjes, H., Dietzel, A. H., Finke, J. H., Glasmacher, B., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.008 · Cited by 161
Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development
Gadade, D. D., & Pekamwar, S. S. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.062 · Cited by 160
Potential of Liposomes for Enhancement of Oral Drug Absorption
Daeihamed, M., Dadashzadeh, S., Haeri, A., & Akhlaghi, M. F. (2016) · Current Drug Delivery · doi:10.2174/1567201813666160115125756 · Cited by 159
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review
LaFountaine, J. S., McGinity, J. W., & Williams, R. O. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0393-y · Cited by 154
Elmowafy, M., Ibrahim, H. M., Ahmed, M. A., Shalaby, K., Salama, A., & Hefesha, H. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1337823 · Cited by 150
In-vitro digestion of curcumin loaded chitosan-coated liposomes
Cuomo, F., Cofelice, M., Venditti, F., Ceglie, A., Miguel, M. G., Lindman, B., & Lopez, F. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.11.047 · Cited by 147
Freag, M. S., Saleh, W. M., & Abdallah, O. Y. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.053 · Cited by 137
Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions
Mikulcová, V., Kašpárková, V., Humpolíček, P., & Buňková, L. (2017) · Molecules · doi:10.3390/molecules22050700 · Cited by 135
Hu, X., Zhang, J., Yu, Z., Xie, Y., He, H., Qi, J., Dong, X., Lü, Y., Zhao, W., & Wu, W. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.06.013 · Cited by 131
Aboalnaja, K. O., Yaghmoor, S., Kumosani, T., & McClements, D. J. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1162154 · Cited by 130
Liquisolid technique and its applications in pharmaceutics
Lu, M., Xing, H., Jiang, J., Chen, X., Yang, T., Wang, D., & Ding, P. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.09.007 · Cited by 126
Self-citationLoftsson, Þ., Moya‐Ortega, M. D., Alvarez‐Lorenzo, C., & Concheiro, Á. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12427 · Cited by 124
Thatipamula, R. P., Palem, C., Gannu, R., et al. (2011) · PubMed · Cited by 121
Xu, Y., Liu, X., Lian, R., Zheng, S., Yin, Z., Lü, Y., & Wu, W. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.020 · Cited by 120
Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents
Gnananath, K., Nataraj, K. S., & Rao, B. G. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.005 · Cited by 118
Ribeiro, L. N. D. M., Franz‐Montan, M., Breitkreitz, M. C., Alcântara, A. C. S., Castro, S. R., Guilherme, V. A., Barbosa, R. D. M., & de Paula, E. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.030 · Cited by 115
Dash, R. N., Habibuddin, M., Humaira, T., & Ramesh, D. (2015) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2015.01.024 · Cited by 114
Tan, S. W., Billa, N., Roberts, C. J., & Burley, J. (2010) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2010.09.030 · Cited by 113
Gonçalves, L., Maestrelli, F., Mannelli, L. D. C., Ghelardini, C., Almeida, A. J., & Mura, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.02.012 · Cited by 112
Valicherla, G. R., Dave, K. M., Syed, A. A., Riyazuddin, M., Gupta, A. P., Singh, A., Wahajuddin, M., Mitra, K., Datta, D. B., & Gayen, J. R. (2016) · Scientific Reports · doi:10.1038/srep26895 · Cited by 110
Size-Dependent Translocation of Nanoemulsions via Oral Delivery
Xia, F., Fan, W., Jiang, S., Ma, Y., Lü, Y., Qi, J., Ahmad, E., Dong, X., Zhao, W., & Wu, W. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b04916 · Cited by 109
Vijayakumar, A., Baskaran, R., Jang, Y. S., Oh, S. H., & Yoo, B. K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0573-4 · Cited by 97
Marano, S., Barker, S. A., Raimi‐Abraham, B. T., Missaghi, S., Rajabi‐Siahboomi, A. R., & Craig, D. Q. M. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.03.021 · Cited by 95
Semalty, A. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.916271 · Cited by 93
Andrade, L. M., Reis, C. D. F., Maione-Silva, L., dos Anjos, J. L. V., Alonso, A., Serpa, R. C., Marreto, R. N., Lima, E. M., & Taveira, S. F. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.015 · Cited by 90
Patel, G. M., Shelat, P., & Lalwani, A. (2016) · Drug Delivery · doi:10.3109/10717544.2016.1141260 · Cited by 89
Oral bioavailability enhancement through supersaturation: an update and meta-analysis
Fong, S. Y. K., Bauer‐Brandl, A., & Brandl, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218465 · Cited by 89
Deng, W., Xie, Q., Wang, H., Ma, Z., Wu, B., & Zhang, X. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.05.002 · Cited by 87
Self-citationNovel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds
BRUSEWITZ, C., SCHENDLER, A., FUNKE, A., WAGNER, T., & LIPP, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.022 · Cited by 86
Keck, C. M., Kovačević, A. B., Müller, R. H., Savic, S. D., Vuleta, G. M., & Milić, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.008 · Cited by 83
Knopp, M. M., Nguyen, J. H., Becker, C., Francke, N. M., Jørgensen, E. B., Holm, P., Holm, R., Mu, H., Rades, T., & Langguth, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.02.007 · Cited by 83
Wang, T., Hu, Q., Zhou, M., Xia, Y., Nieh, M., & Luo, Y. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.022 · Cited by 83
Ali, M. E., & Lamprecht, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.023 · Cited by 82
Safwat, S., Ishak, R. A. H., Hathout, R. M., & Mortada, N. D. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1293681 · Cited by 82
Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.002 · Cited by 78
Zhou, X., Zhang, X., Ye, Y., Zhang, T., Wang, H., Ma, Z., & Wu, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.068 · Cited by 78
Self-citationDesign and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
Ye, Y., Zhang, X., Zhang, T., Wang, H., & Wu, B. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.954585 · Cited by 78
Self-citationAmorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption
Rumondor, A. C. F., Dhareshwar, S. S., & Kesisoglou, F. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.004 · Cited by 78
Improved delivery of poorly soluble compounds using nanoparticle technology: a review
Kalepu, S., & Nekkanti, V. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0283-1 · Cited by 77
Zhang, X., Pan, W., Gan, L., Zhu, C., Gan, Y., & Nie, S. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1645 · Cited by 75
Self-citationPEGylated nanostructured lipid carriers (PEG–NLC) as a novel drug delivery system for biochanin A
Wang, L., Luo, Q., Lin, T., Li, R., Zhu, T., Zhou, K., Ji, Z., Song, J.-W., Jia, B., Zhang, C., et al. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.938082 · Cited by 74
Wu, B., Lu, S., Zhang, L.-J., Zhuo, R., Xu, H., & Huang, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131235 · Cited by 74
Transparent Dispersions of Milk-Fat-Based Nanostructured Lipid Carriers for Delivery of β-Carotene
Zhang, L., Hayes, D. G., Chen, G., & Zhong, Q. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf403512c · Cited by 71
Bioimaging of nanoparticles: the crucial role of discriminating nanoparticles from free probes
Hu, X., Dong, X., Lü, Y., Qi, J., Zhao, W., & Wu, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.002 · Cited by 69
Recent advancements in mechanical reduction methods: particulate systems
Leleux, J. A., & Williams, R. O. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.828217 · Cited by 67
Monteiro, L. O. F., Fernandes, R. S., Oda, C. M. R., Lopes, S. C. D. A., Townsend, D. M., Cardoso, V. N., Oliveira, M. C., Leite, E. A., Rubello, D., & de Barros, A. L. B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.135 · Cited by 67
Optimization of the lyophilization process for long-term stability of solid–lipid nanoparticles
Howard, M. D., Lü, X., Jay, M., & Dziubla, T. D. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.645835 · Cited by 64
Song, Y.-J., Wang, L., Yang, P., Wenslow, R. M., Tan, B., Zhang, H., & Deng, Z. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23538 · Cited by 63
A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis
Mohammad, I. S., He, W., & Yin, L. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2370-0 · Cited by 61
Sharma, V. K., & Pathak, K. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.015 · Cited by 60
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells
Bondì, M. L., Botto, C., Amore, E., Emma, M. R., Augello, G., Craparo, E. F., & Cervello, M. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.055 · Cited by 59
Hsu, H., Huang, R.-F. S., Kao, T.-H., Inbaraj, B. S., & Chen, B. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa5e86 · Cited by 59
Yin, J., Xiang, C., Wang, P., Yin, Y., & Hou, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131167 · Cited by 59
Griesser, J., Burtscher, S., Köllner, S., Nardin, I., Prüfert, F., & Bernkop‐Schnürch, A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.06.025 · Cited by 58
Najlah, M., Kadam, A. N., Wan, K., Ahmed, W., Taylor, K. M. G., & Elhissi, A. M. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.027 · Cited by 55
Thiry, J., Kok, M. G. M., Collard, L., Frère, A., Krier, F., Fillet, M., & Évrard, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.12.001 · Cited by 55
Nanotechnology Versus other Techniques in Improving Drug Dissolution
Kwok, P. C. L., & Chan, H. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990400 · Cited by 53
Patel, J., Dhingani, A., Garala, K., Raval, M. K., & Sheth, N. R. (2013) · Drug Delivery · doi:10.3109/10717544.2013.853709 · Cited by 51
Zhao, X., Yang, C., Kai-liang, Y., et al. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903485716 · Cited by 51
Rushmi, Z. T., Akter, N., Mow, R. J., Afroz, M., Kazi, M., de Matas, M., Rahman, M., & Shariare, M. H. (2016) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2016.09.011 · Cited by 51
Ogawa, N., Hiramatsu, T., Suzuki, R., Okamoto, R., Shibagaki, K., Fujita, K., Takahashi, C., Kawashimà, Y., & Yamamoto, H. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.09.014 · Cited by 51
Hong, L., Zhou, C., Chen, F., Han, D., Wang, C.-Y., Li, J., Chi, Z., & Liu, C. (2017) · Journal of Microencapsulation · doi:10.1080/02652048.2017.1373154 · Cited by 51
Joseph, E., Reddi, S., Rinwa, V., Balwani, G., & Saha, R. N. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.050 · Cited by 48
Rodríguez-Burneo, N., Busquets, M. A., & Estelrich, J. (2017) · Nanomaterials · doi:10.3390/nano7070190 · Cited by 48
Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
Prajapati, S. T., Bulchandani, H. H., Patel, D. M., Dumaniya, S. K., & Patel, C. N. (2013) · Journal of Drug Delivery · doi:10.1155/2013/870579 · Cited by 47
Panatieri, L. F., Brazil, N. T., Faber, K., Medeiros-Neves, B., von Poser, G. L., Rott, M. B., Zorzi, G. K., & Teixeira, H. F. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0550-y · Cited by 47
Characterization of the Dissolution Behavior of Piperine/Cyclodextrins Inclusion Complexes
Ezawa, T., Inoue, Y., Murata, I., Takao, K., Sugita, Y., & Kanamoto, I. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0908-9 · Cited by 47
Christophersen, P. C., Zhang, L., Müllertz, A., Nielsen, H. M., Yang, M., & Mu, H. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1337-z · Cited by 44
Myricetin solid lipid nanoparticles: Stability assurance from system preparation to site of action
Gaber, D. M., Nafee, N. A., & Abdallah, O. Y. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.08.007 · Cited by 42
Kim, J.-E., & Park, Y. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.261 · Cited by 41
Wan, L., Zhang, T., Ye, Y., Zhang, X., & Wu, B. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.011 · Cited by 40
Self-citationMady, F. M., & Aly, U. F. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s135084 · Cited by 39
Shah, A. V., Desai, H. H., Thool, P., et al. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1419365 · Cited by 39
Knopp, M. M., Nguyen, J. H., Mu, H., et al. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9865-6 · Cited by 38
Tian, Z., Yi, Y., Yuan, H., Han, J., Zhang, X., Xie, Y., Lü, Y., Qi, J., & Wu, W. (2013) · Powder Technology · doi:10.1016/j.powtec.2013.07.010 · Cited by 37
Self-citationKeohane, K., Rosa, M., Coulter, I. S., & Griffin, B. T. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1044905 · Cited by 36
Photoresponsive lipid-polymer hybrid nanoparticles for controlled doxorubicin release
Yao, C., Wu, M., Zhang, C., Lin, X., Wei, Z., Zheng, Y., Zhang, D., Zhang, Z., & Liu, X. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa702a · Cited by 35
Self Emulsifying Drug Delivery System (SEDDS) for Phytoconstituents: A Review
Chouhan, N. K., Mittal, V., Kaushik, D. K., Khatkar, A., & Raina, M. (2014) · Current Drug Delivery · doi:10.2174/1567201811666141021142606 · Cited by 34
Martínez, L. M., Videa, M. F., Lopez‐Silva, T. L., Pardo, S. C., Caballero, A., Díaz, V. J. L., & Castorena‐Torres, F. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.06.021 · Cited by 33
Sood, J., Sapra, B., & Tiwary, A. K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0658-0 · Cited by 32
Li, X., Liu, S., Wang, Q., & Lu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87471 · Cited by 31
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs
Esposito, E., Drechsler, M., Mariani, P., Carducci, F., Servadio, M., Melancia, F., Ratano, P., Campolongo, P., Trezza, V., Cortesi, R., et al. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0188-x · Cited by 31
Barmpalexis, P., Grypioti, A. D., Eleftheriadis, G. K., & Fatouros, D. G. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0893-z · Cited by 31
Sauvage, F., Franzè, S., Bruneau, A., Alami, M., Denis, S., Nicolas, V., Lesieur, S., Legrand, F., BARRATT, G. M., Messaoudi, S., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.053 · Cited by 30
Downstream processing from hot-melt extrusion towards tablets: A quality by design approach
Grymonpré, W., Bostijn, N., Herck, S. V., Verstraete, G., Vanhoorne, V., Nuhn, L., Rombouts, P., Beer, T. D., Remon, J. P., & Vervaet, C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.077 · Cited by 26
Balata, G. F., Zidan, A., Abourehab, M. A. S., & Essa, E. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s114724 · Cited by 22
Liquisolid technology: What it can do for NSAIDs delivery?
Bahari, L. A., Shokri, J., Adibkia, K., & Javadzadeh, Y. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.09.014 · Cited by 21
Nnamani, P. O., Ugwu, A. A., Ibezim, E. C., Kenechukwu, F. C., Akpa, P. A., Ogbonna, J. D., Obitte, N. C., Odo, A. N., Windbergs, M., Lehr, C., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s92755 · Cited by 21
Sugumaran, A., Ponnusamy, C., Kandasamy, P., Krishnaswami, V., Rajaguru, P., Kandasamy, R., Lakshmanan, M., & Natesan, S. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.10.005 · Cited by 21
Nanocrystals: From Raw Material to the Final Formulated Oral Dosage Form - A Review
Scholz, P., & Keck, C. M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150901100417 · Cited by 19
Bioactivity of Epigallocatechin Gallate Nanoemulsions Evaluated in Mice Model
Koutelidakis, A. Ε., Argyri, K., Sevastou, Z., Lamprinaki, D., Panagopoulou, E., Paximada, E., Sali, A., Papalazarou, V., Mallouchos, A., Evageliou, V., et al. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.0160 · Cited by 19
Supercritical fluid-mediated Methods to Encapsulate Drugs: Recent Advances and New Opportunities
Naylor, A., Lewis, A. L., & Illum, L. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.125 · Cited by 18
Swain, R. P., & Subudhi, B. B. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1371739 · Cited by 12
Cited by
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Jakubowska, E., & Lulek, J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102357 · Cited by 83
Metadata
- Authors
- Zhang, X., Xing, H., Zhao, Y., & Ma, Z.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-06-23
- Volume
- 10
- Issue
- 3
- Pages
- 74
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2808748074
- Cited by
- 285
- References
- 132
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.